1. Academic Validation
  2. Gene editing in hematopoietic stem cells by co-delivery of Cas9/sgRNA ribonucleoprotein and templates for homology-directed repair in 'all-in-one' lentivirus-derived nanoparticles

Gene editing in hematopoietic stem cells by co-delivery of Cas9/sgRNA ribonucleoprotein and templates for homology-directed repair in 'all-in-one' lentivirus-derived nanoparticles

  • Nucleic Acids Res. 2025 Aug 11;53(15):gkaf767. doi: 10.1093/nar/gkaf767.
Sofie Andersen 1 2 Jonas Holst Wolff 1 Thomas Wisbech Skov 1 Jacob Hørlück Janns 1 Luther John Davis 1 Jakob H Haldrup 1 Didde Haslund 3 Anne Louise Revenfeld 3 Dinko Relkovic 2 Bjarne K Møller 3 Jacob Lund 4 Rasmus O Bak 1 Emil Aagaard Thomsen 1 Jacob Giehm Mikkelsen 1
Affiliations

Affiliations

  • 1 Department of Biomedicine, Aarhus University, Aarhus C 8000, Denmark.
  • 2 RNA and Gene Therapies, Global Research Technologies, Novo Nordisk A/S, Måløv 2760, Denmark.
  • 3 Department of Clinical Immunology, Aarhus University Hospital, Aarhus N 8200, Denmark.
  • 4 Rare Disease Research, Global Drug Discovery, Novo Nordisk A/S, Måløv 2760, Denmark.
Abstract

Repair of double-strand DNA breaks generated by site-directed endonucleases, like Cas9, is the hallmark of gene editing based on homology-directed repair (HDR). HDR uses an exogenous DNA template to restore the cleaved DNA sequence and can facilitate specific gene corrections as well as insertion of genes or partial complementary DNA (cDNA) sequences. For CRISPR/Cas-directed gene editing, co-administration of the Cas9/single guide RNA (sgRNA) ribonucleoprotein (RNP) complex and a DNA template typically involves two different delivery strategies or different types of vehicles. This requires exquisite timing of delivery and may potentially challenge safety and therapeutic applicability. There is a need therefore for technologies that can ferry complete editing tool kits into cells. Here, we demonstrate the use of lentivirus-derived nanoparticles (LVNPs) to transport both RNP complexes and vector RNA, which upon reverse transcription serves as a repair template for HDR-directed gene editing. Such 'all-in-one' LVNPs support targeted gene insertion with reduced off-target effects relative to nucleofection procedures. We show potent editing in the HBB gene in human erythroid progenitor cells as well as HDR-directed editing in hematopoietic stem and progenitor cells. Our findings MARK a first step toward using a single virus-derived vehicle for delivering a full HDR gene editing kit.

Figures
Products